Evidence map›Paper›PMID 28575443›Full record

ArticleILAR journal2017

Accelerating Biomedical Discoveries through Rigor and Transparency.

Judith A Hewitt, Liliana L Brown, Stephanie J Murphy, Franziska Grieder, Shai D Silberberg

Open access · bronzeAbstract read
In one paragraph

Article in ILAR journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Standard Proteoforms and Their Complexes for Native Mass Spectrometry.Journal of the American Society for Mass Spectrometry · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Judith A HewittOffice of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Division of Comparative Medicine, Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director at the National Institutes of Health, Bethesda, MD. Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD. National Institute of Neurological Disorders and Stroke, Bethesda MD.
Liliana L BrownOffice of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Division of Comparative Medicine, Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director at the National Institutes of Health, Bethesda, MD. Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD. National Institute of Neurological Disorders and Stroke, Bethesda MD.
Stephanie J MurphyOffice of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Division of Comparative Medicine, Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director at the National Institutes of Health, Bethesda, MD. Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD. National Institute of Neurological Disorders and Stroke, Bethesda MD.
Franziska GriederOffice of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Division of Comparative Medicine, Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director at the National Institutes of Health, Bethesda, MD. Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD. National Institute of Neurological Disorders and Stroke, Bethesda MD.
Shai D SilberbergOffice of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Office of Genomics and Advanced Technologies, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD. Division of Comparative Medicine, Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director at the National Institutes of Health, Bethesda, MD. Office of Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD. National Institute of Neurological Disorders and Stroke, Bethesda MD.
Office of the Director · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Difficulties in reproducing published research findings have garnered a lot of press in recent years. As a funder of biomedical research, the National Institutes of Health (NIH) has taken measures to address underlying causes of low reproducibility. Extensive deliberations resulted in a policy, released in 2015, to enhance reproducibility through rigor and transparency. We briefly explain what led to the policy, describe its elements, provide examples and resources for the biomedical research community, and discuss the potential impact of the policy on translatability with a focus on research using animal models. Importantly, while increased attention to rigor and transparency may lead to an increase in the number of laboratory animals used in the near term, it will lead to more efficient and productive use of such resources in the long run. The translational value of animal studies will be improved through more rigorous assessment of experimental variables and data, leading to better assessments of the translational potential of animal models, for the benefit of the research community and society.

Indexed as

Disease Models, AnimalAnimalsBiomedical ResearchInformation Storage and RetrievalReproducibility of Resultsanimal modelsbiasqualificationqualityreproducibilityrigorstatisticstransparency

Identifiers

PMID28575443
PMCPMC6279133
OpenAlexW2619552296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.